Characterization of Posttranslationally Modified PHF-1 Tau Peptides Using Gaussian Accelerated Molecular Dynamics Simulation
Author:
Barbhuiya Tabassum Khair,
Jayarathna Dulari K.,
Gilmour Raechelle,
Smet-Nocca Caroline,
Gandhi Neha S.ORCID
Reference59 articles.
1. Schneider A, Mandelkow E (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5:443–457. https://doi.org/10.1016/j.nurt.2008.05.006
2. Gao Y-L, Wang N, Sun F-R, Cao X-P, Zhang W, Yu J-T (2018) Tau in neurodegenerative disease. Ann Transl Med 6:1–13. https://doi.org/10.21037/atm.2018.04.23
3. Pedersen JT, Sigurdsson EM (2015) Tau immunotherapy for Alzheimer’s disease. Trends Mol Med 21:394–402. https://doi.org/10.1016/j.molmed.2015.03.003
4. Henriques J, Cragnell C, Skepö M (2015) Molecular dynamics simulations of intrinsically disordered proteins: force field evaluation and comparison with experiment. J Chem Theory Comput 11:3420–3431. https://doi.org/10.1021/ct501178z
5. Jin F, Gräter F (2021) How multisite phosphorylation impacts the conformations of intrinsically disordered proteins. PLoS Comput Biol 17:e1008939. https://doi.org/10.1371/journal.pcbi.1008939